Preparation of a novel type I feline coronavirus virus-like particle vaccine and its immunogenicity in mice and cats

Qun Zhou,Xin Song,Yan Li,Jian Huang,Qi-Sheng Yu,Gu-Nan Den,Jia-Qi Zhang,Chen-Xi Zhu,Bin Zhang
DOI: https://doi.org/10.1016/j.micpath.2024.106795
Abstract:Feline coronavirus (FCoV) infection is a leading cause of death in cats. In this study, we produced FCoV-I virus-like particles (VLPs) containing E, M, N, and S proteins using a baculovirus expression system and mixed VLPs with the adjuvants MF59 and CpG 55.2 to prepare an VLP/MF59/CpG vaccine. After immunization of mice with the vaccine, IgG specific antibodies titers against S and N proteins increased to 1:12,800, and IFN-γ+ and IL-4+ splenocytes were significantly increased. Following immunization of FCoV-negative cats, the S protein antibodies in immunized cats (5/5) increased significantly, with a peak of 1:12,800. Notably, after booster vaccination in FCoV-positive cats, a significant reduction in viral load was observed in the feces of partial cats (4/5), and the FCoV-I negative conversion was found in two immunized cats (2/5). Therefore, the VLP/MF59/CpG vaccine is a promising candidate vaccine to prevent the FCoV infection.
What problem does this paper attempt to address?